CANF
Can-Fite BioPharma Ltd.

12,969
Mkt Cap
$51.22M
Volume
200,428.00
52W High
$2.50
52W Low
$0.46
PE Ratio
-0.25
CANF Fundamentals
Price
$0.4335
Prev Close
$0.461
Open
$0.461
50D MA
$0.6022
Beta
0.61
Avg. Volume
160,295.48
EPS (Annual)
-$1.09
P/B
1.46
Rev/Employee
$135,439.80
Loading...
Loading...
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
5

Frequently Asked Questions

What is Market Cap of Can-Fite Biopharma Ltd - ADR?
What is the 52-week high for Can-Fite Biopharma Ltd - ADR?
What is the 52-week low for Can-Fite Biopharma Ltd - ADR?
What is Can-Fite Biopharma Ltd - ADR stock price today?
What was Can-Fite Biopharma Ltd - ADR stock price yesterday?
What is the PE ratio of Can-Fite Biopharma Ltd - ADR?
What is the Price-to-Book ratio of Can-Fite Biopharma Ltd - ADR?
What is the 50-day moving average of Can-Fite Biopharma Ltd - ADR?
How many employess does Can-Fite Biopharma Ltd - ADR has?

Latest CANF News

View
No CANF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.